Author:
Sidorova L. P.,Tseitler T. A.,Emel’yanov V. V.,Savateeva E. A.,Maksimova N. E.,Mochul’skaya N. N.,Chereshnev V. A.,Chupakhin O. N.
Publisher
Springer Science and Business Media LLC
Subject
Drug Discovery,Pharmacology
Reference14 articles.
1. US Patent 6 028 068, Chem. Abstr., 127, 149163 (1997).
2. Russian Federation Patent 2411936, Chem. Abstr., 154, 251130 (2011).
3. PCT Rus. Patent 2259371, Chem. Abstr., 143, 229887 (2005).
4. A. Sarapultsev, O. Chupakhin, M. Rantsev, et al., Adv. Biosci. Biotechnol., 3, 442 – 448 (2012).
5. P. Sarapultsev, O. Chupakhin, A. Sarapultsev, et al., Int. J. Exp. Pathol., 93(1), 18 – 23 (2012).
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antioxidant properties of 2,5-substituted 6H-1,3,4-thiadiazines promising for experimental therapy of diabetes mellitus;Russian Chemical Bulletin;2022-12
2. 1,3,4-Oxadiazines and 1,3,4-Thiadiazines;Comprehensive Heterocyclic Chemistry IV;2022
3. Synthesis and Antiglycating Activity of 2-Aminopropylmorpholino-5-Aryl-6H-1,3,4-Thiadiazine Dihydrobromides and 2-Aminopropylmopholino-5-Thienyl-6H-1,3,4-Thiadiazine Dihydrobromides;Pharmaceutical Chemistry Journal;2020-01
4. Structure—activity relationship in the series of 1,3,4-6Н-thiadiazines correcting metabolic disorders in experimental diabetes mellitus;Russian Chemical Bulletin;2017-10